An edition of Competitive problems in the drug industry
(1967)
Competitive problems in the drug industry
hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session ...
by United States. Congress. Senate. Select ...
Share
×Close
Last edited by Ben Companjen
May 17, 2012 | History
This work doesn't have a description yet. Can you add one?
Buy this book
| Edition | Availability |
|---|---|
1
|
aaaa
|
Book Details
Table of Contents
pt. 28. Oral hypoglycemic drugs.
pt. 29. Government procurement (vol. 8), (Bioequivalence and bioavailability).
v. 30.Pharmaceutical industry and medical education (vol. 1).
pt. 31. Safety and efficacy of anti-obesity drugs.
pt. 32. Pharmaceutical company practices in labeling and promoting prescription drugs sold in Latin America.
pt. 33 Drug quality, competition, and government procurement of drugs.
Pt. 34. Hearings before the Select Committee on Small Business, Jan. 31, Feb. 1 and 5, 1979.
Edition Notes
Hearings held May 15, 1967-
Pts. 1-32 of these hearings held before the subcommittee under its earlier name: Subcommittee on Monopoly.
Oral hypoglycemic drugs.
Includes bibliographical references.
The Physical Object
Edition Identifiers
Work Identifiers
Community Reviews (0)
Lists
| May 17, 2012 | Edited by Ben Companjen | merge authors |
| December 3, 2010 | Edited by Open Library Bot | Added subjects from MARC records. |
| December 10, 2009 | Created by WorkBot | add works page |